Toxic dose-range findings and post-treatment reversibility assessment in female rats on a three-month oral treatment with the progestational agent allylestrenol.
Marcy
R
R
Zirinis
P
P
D000830:Animals, Laboratory; D001695:Biology; D001769:Blood; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D005193:Family Planning Services; D010827:Physiology; D012106:Research
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral
Animals, Laboratory; Biology; Clinical Research; Comparative Studies; Contraception; Contraceptive Agents, Female--administraction and dosage; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--administraction and dosage; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--administraction and dosage; Contraceptive Agents--side effects; Contraceptive Methods--side effects; Family Planning; Hematological Effects; Hemic System; Oral Contraceptives--side effects; Physiology; Research Methodology; Studies